Medical science has moved forward by leaps and bounds in recent years, and yet for too many injured workers, their initial work-related injury and subsequent medical treatment is only the start of an all-too-familiar downward spiral that often ends in …
As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc., could charge up to $10,000 for the treatment. Then a small but increasingly …
Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to limit annual increases to under 10 percent – but the tactic is doing little to salve critics, including President-elect Donald Trump, who on Wednesday …
U.S. Democratic presidential candidate Hillary Clinton proposed on Tuesday a $250 monthly cap on out-of-pocket prescription drug costs and other measures to stop what she called “price gouging” by pharmaceutical companies. At a campaign stop in Iowa, Clinton rolled out …
Pharmaceutical companies are enlisting Fitbits and other gadgets strapped to patients’ wrists, chests and skin as a way to bring drugs to market faster. What began as an aid for athletes and dieters to track their movements is quickly becoming …
The battle over soaring U.S. drug prices is heading for the states. With the price of some treatments topping $100,000, patient groups are pushing for state laws to make sure insurers cover most of the costs. Their campaign is backed …
